Jeffrey M. Jonas, Director at Sage Therapeutics, Inc. (SAGE), sold 23,286 shares at $44.47 ($1.0M) on 2023-02-10, disclosed to the SEC on 2023-02-10.
Open-market sale of $1.0M SAGE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.47 | 7,805 | $347K | 33.4% |
| 2 | $44.47 | 7,805 | $347K | 33.4% |
| 3 | $44.90 | 3,838 | $172K | 16.6% |
| 4 | $44.90 | 3,838 | $172K | 16.6% |
| Total | $44.61 avg | 23,286 | $1.0M | 100% |
| Filing → |
| KRTX | SELL | 2023-07-05 | $6.0M | — | Filing → |
| SAGE | BUY | 2019-12-10 | $482K | — | Filing → |
| SAGE | SELL | 2019-05-29 | $29.9M | — | Filing → |